Navigation Links
How one virus uses mimicry to replicate successfully
Date:10/31/2007

(PHILADELPHIA) Both viruses and cancers subvert the growth-control machinery in a cell to serve their own needs. According to a new study, at least one virus uses mimicry to gain access to that machinery.

A common target for both is a cell protein called the retinoblastoma protein, or pRb, which serves to block cell division when potentially cancer-causing gene mutations are present. First identified in pediatric tumors of the retina, this tumor suppressor protein has since been found to play a role in many other forms of cancer when disrupted.

A number of viruses produce proteins that specifically target pRb, and scientists have studied these viruses and their proteins closely to better understand how normal cells can turn cancerous. Among such viruses are the adenoviruses, which produce a protein called E1A that interferes with pRb and its ability to control unwanted cell division. Adenoviruses are not themselves cancer causing, but a better understanding of how they interact with pRb might well shed light on related mechanisms used by other viruses to trigger cancers. For example, a protein that is functionally equivalent to E1A from human papillomavirus, called E7, causes cervical cancer in the cells it infects.

Until now, investigators had been unable to obtain detailed information about how E1A disrupts the normal function of pRb. In a new study, however, featured on the cover of the November 1 issue of the journal Genes & Development, researchers at The Wistar Institute have solved the three-dimensional structure of a molecular complex of pRb and E1A, providing the first atomic view of the viral E1A protein in action.

The findings show that that E1A operates in a novel way, mimicking a normal cellular protein called E2F that ordinarily binds to pRb in a controlled and regulated fashion.

The structural similarities between E1A and E2F are surprising and striking, says Ronen Marmorstein, Ph.D., a professor in
'/>"/>

Contact: Franklin Hoke
hoke@wistar.org
215-898-3716
The Wistar Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Ebola Virus - Outbreak Claims More Lives In Uganda.
3. Experimental treatment for Ebola Virus Shows promising results in mice
4. Virus Combats Brain Tumour
5. Virus killer
6. Minor mutations in HIV virus
7. Virus makes Hodgkin’s disease more deadl
8. Infertility in relation with virus
9. Birds breed viruses
10. Hidden influenza virus protein found
11. Pain Killers Keep the Virus Away

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Dec. 4 The following i...inz Family Philanthropies: ,, Credit Senators J...gnificant contribution to the health care debate: ...ns living with Phenylketonuria (PKU) control their...rs living with serious chronic conditions are trea...
(Date:12/4/2009)... ischemic stroke are at higher lifetime risk for a... reduce that risk. One of the simplest regimens in... as blood thinners, of which the most common is as...whether the use of antithrombotic medications amon...iod found that in each of the years, approximately...
(Date:12/4/2009)... Tender Corp., a leading manufacturer of over-the...gned to enhance consumers’ quality of life, ...ed American Podiatric Medical Association (APMA) S..., HealthiFeet®. , (P...manufacturer of over-the-counter topical cream and...
(Date:12/4/2009)...Ind., Dec. 4 Hill-Rom Ho...scal 2010 first quarter dividend of $0.1025 per sh...d of Directors on December 3, 2009, and is payable...s of December 17, 2009. ,, ABOUT HILL-ROM ...wide manufacturer and provider of medical technolo...
(Date:12/4/2009)...nn., Dec. 4 MedClean Tec...nnounced the Company has entered into a preferred ..., LLC, a Delaware limited liability company, doin...LLC. Pursuant to the Purchase Agreement, MedClean ... The Company agreed to sell up to 750 shares of it...
Breaking Medicine News(10 mins):Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Are stroke survivors taking their medicine? 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 3
...y College London and Imperial College London have ...sy environment, such as a pub or in a crowd. // Th...ain work together to make sense of what it hears, ...perience of people who rely on cochlear implants, ...
...tting ready to go home. Savage, who received ...mber last, says he feels sensation in his// new li...and in a ghastly machine press accident. Savag...ansplant surgeries. Savage, who reported sensa...
...r educated about the risks of exposing children to...h researchers.// Results from a 14-year stu...e more likely to suffer respiratory problems. ...rn Australia say the evidence supports a ban on sm...
...ommended a maximum residue limit (MRL) of one part... the panel has suggested that the limit should be ...nsumer safety. The panel is headed by the ch...f a controversy over pesticide residues in colas. ...
... issue in quality of life for patients with chroni...peaker, advocate and rheumatology patient, is// ou...nals address this aspect of care. During an hour-l... experiences. Perhaps most importantly, she’ll be ...
...rs seem to have tapped nature, in the form of an e...a possible cure for a notorious type of childhood/...a accounts for nearly 3% of all cancers in childre...'Brien of the University of California, San Franci...
Other Medicine News:Health News:Making Sense of the World Through a Cochlear Implant 2Health News:Destroying Taboos to Improve Patient Care 2
(Date:12/3/2009)...c. 3 Radiology imaging leader MEDR...ration capabilities at the November 2009 Radiology...t.PACS(TM) product, enabling the first radiology ...t release in the company,s newly branded Certegra...://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
(Date:12/3/2009).... 3 Wound Management...rapidly growing provider of specialty medical prod... Industry Representative Association (HIRA) to ser...ing representative to market the company,s core Ce...IRA will market and sell Wound Management Technolo...
(Date:12/3/2009)...re-FirstCall/ -- Cardium Therapeutics (NYSE Amex: ...diary, Tissue Repair Company, submitted a 510(k) p...d Drug Administration (FDA) seeking marketing clea...sed on positive data from the Company,s recently c...submission with the FDA covers Excellagen XL(TM) ...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 1Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 2Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 1SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 2SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 4SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 5SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 6SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 7SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 8SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 9SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 10Combo Treatment May Ease Depression After Stroke 53891 1Combo Treatment May Ease Depression After Stroke 53891 2
TME 228 TS
TME 63 TC
TME 66 S
TME 64 S-3
Medicine Products: